This is supported by previous reports where Boc-protected amino acid derivatives, particularly sarcosine derivatives, demonstrated both potent anticancer activity and high selectivity toward tumor cells, consistent with our findings that Boc-containing LLPs exhibit potent cytotoxicity with minimal effects on normal cells [86]. The gene discussed is BOC; the disease is neoplasm.